These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. [Mediators of the allergic reaction. Slow reacting substance (SRS-A)]. Naranjo P Allergol Immunopathol (Madr); 1975; 3(4):239-54. PubMed ID: 5879 [TBL] [Abstract][Full Text] [Related]
5. The role of slow-reacting substance in asthma. Brocklehurst WE Adv Drug Res; 1970; 5():109-13. PubMed ID: 4923800 [No Abstract] [Full Text] [Related]
6. Abnormal mucociliary transport in allergic patients with antigen-induced bronchospasm: role of slow reacting substance of anaphylaxis. Ahmed T; Greenblatt DW; Birch S; Marchette B; Wanner A Am Rev Respir Dis; 1981 Aug; 124(2):110-4. PubMed ID: 7258824 [TBL] [Abstract][Full Text] [Related]
7. [The effects of Ca++ antagonists nifedipine and nicardipine on slow reacting substance of anaphylaxis (SRS-A) mediated bronchoconstriction in guinea pig]. Koshino T Arerugi; 1984 Jan; 33(1):6-16. PubMed ID: 6743030 [No Abstract] [Full Text] [Related]
8. Are the leukotrienes involved in the bronchial asthma? Votava Z Biomed Biochim Acta; 1984; 43(8-9):S434-7. PubMed ID: 6517906 [TBL] [Abstract][Full Text] [Related]
9. Effect of a Ca2+ antagonist, nifedipine, on the experimental asthma mediated mainly by slow reacting substance of anaphylaxis. Koshino T; Fujimura M; Minami S; Nishioka S; Okafuji K; Kanamori K; Matsuda T; Ishizaki T; Saga T; Miyabo S Arzneimittelforschung; 1985; 35(8):1231-6. PubMed ID: 4074440 [TBL] [Abstract][Full Text] [Related]
11. [Leukotrienes and the lung]. Leitch AG Rev Mal Respir; 1984; 1(6):329-36. PubMed ID: 6099600 [TBL] [Abstract][Full Text] [Related]
12. Slow-reacting substance of anaphylaxis. Piper PJ Ann R Coll Surg Engl; 1978 May; 60(3):201-4. PubMed ID: 348012 [No Abstract] [Full Text] [Related]
13. Double bonds, asthma, anaphylaxis and leukotriene C. Abramson HA J Asthma Res; 1979 Apr; 16(3):vi-vii. PubMed ID: 489506 [No Abstract] [Full Text] [Related]
14. [Role of the leukotrienes in asthma]. Underner M; Patte F Allerg Immunol (Paris); 1986 Sep; 18(7):5-10. PubMed ID: 2840090 [TBL] [Abstract][Full Text] [Related]
15. Pulmonary and vascular effects of leukotrienes imply involvement in asthma and inflammation. Hedqvist P; Dahlén SE Adv Prostaglandin Thromboxane Leukot Res; 1983; 11():27-32. PubMed ID: 6221536 [No Abstract] [Full Text] [Related]
16. Release of slow-reacting substance of anaphylaxis in the rat: polymorphonuclear leukocyte. Orange RP; Valentine MD; Austen KF Science; 1967 Jul; 157(3786):318-9. PubMed ID: 6028400 [TBL] [Abstract][Full Text] [Related]
17. Slow reacting substance of anaphylaxis (SRS-A): cellular controls of synthesis and biological effects of its constituent leukotrienes. Lewis RA; Austen KF Prog Lipid Res; 1981; 20():713-8. PubMed ID: 7342125 [No Abstract] [Full Text] [Related]
18. The Paul Kallós Memorial Lecture. From slow-reacting substance of anaphylaxis to leukotriene C4 synthase. Austen KF Int Arch Allergy Immunol; 1995; 107(1-3):19-24. PubMed ID: 7613129 [TBL] [Abstract][Full Text] [Related]
19. [Role of the eicosanoids: prostaglandins, prostacyclin, thromboxane and leukotrienes in the pathogenesis of bronchial asthma and other lung diseases]. Karaulov AV; Silvestrov VP; Pomoĭnetskiĭ VD; Zakharov VN; Masenko VP Ter Arkh; 1986; 58(3):123-30. PubMed ID: 3520918 [No Abstract] [Full Text] [Related]
20. Effects of Ca2+ antagonist, nicardipine, on experimental asthma with special reference to slow reacting substance of anaphylaxis. Koshino T; Fujimura M; Nishioka S; Okafuji K; Minami S; Kanamori K; Matsuda T; Ishizaki T; Saga T; Miyabo S Allergy; 1985 Jul; 40(5):311-3. PubMed ID: 4037252 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]